About Sainor Pharma Private Limited
Data last updated:
Sainor Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 February 2004.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC042653. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.54 Cr. It was led by directors including Uddagiri Tata Rao (Managing Director) and Anjaneya Pattabhi Rameswara Rao Chandana.
Its last annual general meeting (AGM) was held on 26 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Plot No. 31 Phase V Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2016, the company reported a revenue of ₹48.47 Cr. For the same year it recorded a net profit of ₹29.55 Lakh (net margin 0.6%) and EBITDA of ₹2.23 Cr (EBITDA margin 4.6%).
As per MCA filings, the company had satisfied charges of ₹19.13 Cr on record.
The last known website on record is sainorpharma.net.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 31 Phase V Ida Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sainor Pharma Private Limited
The main business activity of Sainor Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sainor Pharma Private Limited FY 2016 filings available
Sainor Pharma Private Limited reported revenue of ₹48.47 Cr for FY 2016.
Financial Statement Summary of Sainor Pharma Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | ₹48.47 Cr | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹2.23 Cr | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹29.55 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Sainor Pharma Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.6% | •••• |
| Net Profit Margin | 0.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sainor Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sainor Pharma Private Limited
Sainor Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kivi Labs Limited | ₹49.21 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Por, Gujarat, India |
| Century Super Speciality Hospitals Private Limited | ₹49.06 Cr (FY 2025) | •••• | •••• | 151.0% | •••• | Hyderabad, Telangana, India |
| Atoz Pharmaceuticals Private Limited | ₹49.04 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ambattur Chenai, Tamil Nadu, India |
| Protech Bio Systems Private Limited | ₹48.99 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | New Delhi, Delhi, India |
| Montage Laboratories Private Limited | ₹48.49 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Himatnagar, Gujarat, India |
| Sainor Pharma Private Limited this company | ₹48.47 Cr (FY 2016) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Glow Pharma Private Limited | ₹48.18 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Rhydburg Pharmaceuticals Ltd | ₹48.17 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Delhi, India |
| Edkem Pharmaceuticals Limited | ₹48.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Ahmedabad, Gujarat, India |
| Indasi Lifescience Private Limited | ₹48.01 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Daman, Daman and Diu, India |
| R.K. Laboratories Private Limited | ₹47.96 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Sainor Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sainor Pharma Private Limited
Sainor Pharma Private Limited is audited by B. Nagaraja Rao & Associates for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B. Nagaraja Rao & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sainor Pharma Private Limited
Sainor Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjaneya Pattabhi Rameswara Rao Chandana Also directs: Organor Chemicals LLP, Srisaichandana Api Private Limited, Sainor Laboratories Private Limited and 5 more | Director | 06 Jun 2013 | 13 Years 4 Months | As last reported |
| Pullaiah Naidu Sundara | Director | 13 Feb 2004 | 22 Years 7 Months | As last reported |
| Uddagiri Tata Rao Also directs: Organor Chemicals LLP, Sri Veera Hanuman Constructions LLP, Srisaichandana Api Private Limited and 2 more | Managing Director | 13 Feb 2004 | 22 Years 7 Months | As last reported |
Ownership and Shareholding of Sainor Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sainor Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2012 | State Bank of India | ₹17.63 Cr | Satisfied |
| 26 Sep 2005 | Union Bank of India | ₹1.5 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Sainor Pharma Private Limited
Employment history and EPFO contributions of people linked to Sainor Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Sainor Pharma Private Limited
Sainor Pharma has one previous CIN (Corporate Identification Number): U24239AP2004PTC042653. The current CIN is U24239TG2004PTC042653, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC042653 | Current |
| U24239AP2004PTC042653 | Previous |
Recent Activity on Sainor Pharma Private Limited
Sainor Pharma Private Limited has 8 board changes on record since 2004: 3 appointments and 5 cessations. The latest: Venkateswara Rao Talupula ceased to be Director on 16 Jun 2016.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sainor Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sainor Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sainor Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sainor Pharma Private Limited
Sainor Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sainor Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sainor Pharma Private Limited
Sainor Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Sainor Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 13 February 2004 and is registered under CIN U24239TG2004PTC042653. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Sainor Pharma was incorporated on 13 February 2004. It is registered with the Registrar of Companies, Hyderabad.
Sainor Pharma had 3 directors:
- Uddagiri Tata Rao - Managing Director
- Anjaneya Pattabhi Rameswara Rao Chandana - Director
- Pullaiah Naidu Sundara - Director
The CIN (Corporate Identification Number) of Sainor Pharma is U24239TG2004PTC042653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sainor Pharma is at Plot No. 31 Phase V Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
Sainor Pharma can be reached through the website sainorpharma.net. Its registered office is in Hyderabad, Telangana, India.
Sainor Pharma reported revenue of ₹48.47 Cr for FY 2016.
Sainor Pharma has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.54 Cr.
Sainor Pharma reported a net profit of ₹29.55 Lakh (net margin 0.6%) and EBITDA of ₹2.23 Cr (EBITDA margin 4.6%) for FY 2016, as per its filed financial statements.
No. Sainor Pharma has 2 GST registrations on record and all of them are cancelled or inactive.